𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Relative risk of prostate cancer for men with affected relatives: Systematic review and meta-analysis

✍ Scribed by Deborah Watkins Bruner; Dirk Moore; Alicia Parlanti; Joanne Dorgan; Paul Engstrom


Publisher
John Wiley and Sons
Year
2003
Tongue
French
Weight
273 KB
Volume
107
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

An increased risk of prostate cancer associated with a family history of prostate cancer has been documented in multiple published reports. Risk has been shown to vary by degree of relationship and age of onset of disease in the affected relative. Several studies, using various designs, have estimated the relative risk (RR) for these associations. The purpose of our study was to identify and summarize published reports on the relationship between risk of prostate cancer and family history, which is defined as having a father, brother, any first‐ or second‐degree relative or other relative affected with prostate cancer. A Medline and manual search from 1982 to 2000 identified 24 studies that reported RR and confidence intervals (CI) and satisfied inclusion criteria. Pooled RR estimates based upon a weighted average model were as follows: any affected family member RR = 1.93, CI 1.65–2.26; affected first‐degree relative RR = 2.22, CI 2.06–2.40; affected second‐degree relative RR = 1.88, CI 1.54–2.30; father with prostate cancer RR = 2.12, CI 1.82–2.51; and brother with prostate cancer RR = 2.87, CI 2.21–3.73). Statistical comparison of pooled data demonstrated that the RR is significantly higher for affected brother than for affected father (p < 0.03). A sensitivity analysis demonstrated that these results are robust with respect to population bias. This meta‐analysis confirms that risk of prostate cancer is associated with family history of disease and improves the quantification of this risk. © 2003 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Meta-analysis for combining relative ris
✍ Dennis, Leslie K. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 1 views

## BACKGROUND. Prostate cancer has become the most common cancer among men in the United States, but little is known about factors associated with prostate cancer incidence. METHODS. A meta-analysis of studies published prior to July 1998 was conducted to pool relative risk (RR) estimates from the

Empiric risk of prostate carcinoma for r
✍ Maurice P.A. Zeegers; Annemarie Jellema; Harry Ostrer 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

## Abstract ## BACKGROUND Although narrative reviews have concluded that there is strong support for familial clustering of prostate carcinoma, the association has never systematically been quantified in reviews. The purpose of this meta–analysis was to summarize and quantify the recurrence risk r

Systematic review and meta-analysis of m
✍ David J. Samson; Jerome Seidenfeld; Brian Schmitt; Vic Hasselblad; Peter C. Albe 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 1 views

## Abstract ## BACKGROUND The current systematic review and meta‐analysis compared monotherapy and combined androgen blockade in the treatment of men with advanced prostate carcinoma. Outcomes of interest included overall, cancer specific, and progression‐free survival; time to treatment failure;

The clinical management of patients with
✍ Patricia Harnden; Brian Naylor; Michael D. Shelley; Hayley Clements; Bernadette 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 437 KB 👁 1 views

## Abstract Clinically localized prostate cancer is associated with a wide variation in biologic behavior, and men with the less aggressive form of the disease may never develop symptoms. There has been a rise in prostate cancer incidence in countries in which the blood test for prostatic‐specific